» Authors » Chien-Wei Chen

Chien-Wei Chen

Explore the profile of Chien-Wei Chen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 96
Citations 700
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chiu H, Safron N, Passlack M, Chao T, Su S, Mao P, et al.
Nano Lett . 2025 Mar; 25(10):3981-3988. PMID: 40032618
In this work, we address the off-state leakage current challenge, while simultaneously demonstrating high drive current per CNT, in NMOS and PMOS carbon nanotube field-effect transistors (CNFETs). Increasing the bandgap...
2.
Chen S, Yang Y, Tseng Y, Chiou K, Huang P, Chih J, et al.
ACS Nano . 2024 Dec; 19(1):704-711. PMID: 39704722
Flexible and wearable electronics are experiencing rapid growth due to the increasing demand for multifunctional, lightweight, and portable devices. However, the growing demands of interactive applications driven by the rise...
3.
Chang Y, Wang S, Lee Y, Huang C, Hsu C, Weng T, et al.
Adv Mater . 2024 Dec; 37(5):e2413212. PMID: 39654351
Amorphous oxide semiconductors (AOS) are pivotal for next-generation electronics due to their high electron mobility and excellent optical properties. However, InO, a key material in this family, encounters significant challenges...
4.
Cao X, Chen C, Yin K, Wang T, Huang Y, Chen P, et al.
J Biochem Mol Toxicol . 2024 Dec; 38(12):e70074. PMID: 39620438
Triple negative breast cancer (TNBC) is characterized by high heterogenicity and aggressiveness and autophagy plays a complicated role in cancer development. Zingerone is reported to possess multiple pharmacological activities, including...
5.
Wandel S, Desai A, Chen C, McMurray J, Packer M, Solomon S, et al.
Eur Heart J . 2024 Nov; 45(47):5087-5099. PMID: 39515836
Background And Aims: Heart failure endpoints in cardiovascular outcome trials are commonly identified through centralized adjudication of investigator-reported events. It remains unclear whether central adjudication improves the accuracy of treatment...
6.
Liu S, Chen L, Chung Y, Chen C, Wu G, Chang Y, et al.
J Nutr Biochem . 2024 Sep; 135:109762. PMID: 39251145
Glucosamine (GlcN) is one of the dietary supplements used in the treatment of osteoarthritis. Endogenously, GlcN is synthesized from glucose through the hexosamine pathway. In addition to ameliorating arthritis, several...
7.
Li C, Chen C, Kao C, Hsu Y, Lee C, Lin C, et al.
Int J Surg . 2024 Aug; 110(10):6470-6483. PMID: 39093851
Background: To examine the application of quantitative 2-dimensional phase-contrast MRI (2D PC-MRI) for treating patients with pelvic congestion syndrome (PCS). Materials And Methods: The authors conducted a retrospective cross-sectional analysis...
8.
Patel-Murray N, Zhang L, Claggett B, Xu D, Serrano-Fernandez P, Healey M, et al.
J Am Heart Assoc . 2024 Jun; 13(13):e033544. PMID: 38904251
Background: Prognostic markers and biological pathways linked to detrimental clinical outcomes in heart failure with preserved ejection fraction (HFpEF) remain incompletely defined. Methods And Results: We measured serum levels of...
9.
Elhadad M, Del C Gomez-Alonso M, Chen C, Neumeyer S, Delerue T, Rathmann W, et al.
Cardiovasc Diabetol . 2024 May; 23(1):181. PMID: 38811951
Background And Aims: Atherosclerosis is the main cause of stroke and coronary heart disease (CHD), both leading mortality causes worldwide. Proteomics, as a high-throughput method, could provide helpful insights into...
10.
Liu S, Chen L, Jhong Y, Chen C, Hsiao L, Ku H, et al.
Clin Sci (Lond) . 2024 May; 138(12):711-723. PMID: 38804865
Myopenia is a condition marked by progressive decline of muscle mass and strength and is associated with aging or obesity. It poses the risk of falling, with potential bone fractures,...